Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Moots

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Lupus|March 16, 2019
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritisEmd Smith, E Al-Abadi, K Armon, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Lupus|April 3, 2020
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groupsJ S Massias, E M D Smith, E Al-Abadi, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Lupus|March 16, 2019
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritisEmd Smith, E Al-Abadi, K Armon, et al.
Arthritis Care & Research|May 31, 2014
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry resultsM Juarez, T E Toms, P de Pablo, et al.
Lupus|April 3, 2020
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groupsJ S Massias, E M D Smith, E Al-Abadi, et al.
Pageof 3